PDCD1 and hypothyroidism: Hypothyroidism is the most frequent manifestation of thyroid irAEs, and it usually occurs 6 weeks after subclinical hyperthyroidism, in the context of destructive thyroiditis (in 30-40% of the patients treated with anti-PD-1/PD-L1 antibodies).